Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 1-13 , March 2007

DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery

  • Barbara Ruozi, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Renata Battini, PhD

      Affiliations

    • Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Monica Montanari, PhD

      Affiliations

    • Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Adele Mucci, PhD

      Affiliations

    • Department of Chemistry, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Giovanni Tosi, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Flavio Forni, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • ,
  • Maria Angela Vandelli, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy
    • Corresponding Author InformationCorresponding author. Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Received 31 August 2006 ,Accepted 3 January 2007.

References 

  1. Felgner PL, Gadek PR, Holm M, Roman R, Chan HW, Wenz M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84:7413–7417
  2. Pastorino F, Stuart D, Ponzoni M, Allen TM. Targeted delivery of antisense oligonucleotides in cancer. J Control Release. 2001;74:69–75
  3. Zelphati O, Szoka FC. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?. J Control Release. 1996;41:99–119
  4. Cevc G, Blume G, Schatzlein A, Gebauer D, Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev. 1996;18:349–378
  5. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers, Transferosomes. Clin Pharmacokinet. 2003;42:461–474
  6. Cevc G, Schätzlein A, Gebauer D, Blume G. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, transfersomes. In:  Bain KR,  Hadgkraft J,  James WJ,  Waters KA editor. Prediction of percutaneous penetration. vol 3b:Cardiff: STS Publishing; 1993;p. 226–236
  7. Lau KG, Chopra S, Maitani Y. Entrapment of bleomycin in ultra-deformable liposomes. STP Pharma Sci. 2003;13:237–239
  8. El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm. 2000;196:63–74
  9. Cevc G, Blume G. Biological activity and characteristic of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transferosomes. Biochim Biophys Acta. 2003;1614:156–164
  10. Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transferosomes. Biochim Biophys Acta. 2001;1514:191–205
  11. Tanaka H, Makino I. Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor. Biochem Biophys Res Commun. 1992;188:942–948
  12. Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R. Immunosupressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology. 1992;103:617–621
  13. Suh H, Jung EJ, Kim TH, Lee HY, Park YH, Kim KW. Anti-angiogenic activity of ursodeoxycholic acid and its derivatives. Cancer Lett. 1997;113:117–122
  14. Kim A, Lee EH, Choi SH, Kim CK. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials. 2004;25:305–313
  15. Albalak A, Zeidel ML, Zucker SD, Jackson AA, Donovan JM. Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. Biochemistry. 1996;35:7936–7945
  16. Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, et al. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol. 2002;64:1661–1667
  17. Mehta RC, Stecker KK, Cooper SR, Templin MV, Tsai YJ, Condon TP, et al. Intracellular adhesion molecule-1 suppression in skin by topical delivery of antisense oligonucleotides. J Invest Dermatol. 2000;115:805–812
  18. Gao WY, Hanes RN, Vazquez-Padua MA, Stein CA, Cohen JS, Cheng YC. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother. 1990;34:808–812
  19. Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, et al. C-myc olideoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Cancer Res. 1998;58:283–289
  20. Lee YS, Dlugosz AA, McKay R, Dean NM, Yuspa SH. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes. Mol Carcinog. 1997;18:44–53
  21. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1988;106:761–771
  22. Xu Z, Pilch DS, Srinivasan AR, Olson WK, Geacintov NE, Breslauer KJ. Modulation of nucleic acid structure by ligand binding: induction of a DNA-RNA-DNA hybrid triplex by DAPI intercalation. Bioorg Med Chem. 1997;5:1137–1147
  23. Weisman S, Hirsch-Lerner D, Barenholz Y, Talmon Y. Nanostructure of cationic lipid-oligonucleotide complexes. Biophys J. 2004;87:609–614
  24. Ruozi B, Battini R, Tosi G, Forni F, Vandelli MA. Liposome-oligonucleotides interaction for in vitro uptake by COS I and HaCaT cells. J Drug Target. 2005;13:295–304
  25. Liu F, Yang J, Huang I, Liu D. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer. Pharm Res. 1996;13:1642–1646

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00004-4

doi: 10.1016/j.nano.2007.01.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 1-13 , March 2007

Article Tools

* Image Usage & Resolution